Cambridge Financial Group (Arizona)’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,350
Closed -$305K 170
2025
Q4
$305K Hold
3,350
0.11% 134
2025
Q3
$268K Sell
3,350
-252
-7% -$21.5K 0.09% 147
2025
Q2
$327K Buy
3,602
+252
+8% +$23K 0.12% 111
2025
Q1
$314K Hold
3,350
0.13% 106
2024
Q4
$305K Hold
3,350
0.13% 104
2024
Q3
$348K Hold
3,350
0.14% 95
2024
Q2
$325K Hold
3,350
0.15% 92
2024
Q1
$302K Hold
3,350
0.14% 95
2023
Q4
$267K Buy
+3,350
New +$252K 0.14% 103

Other funds holding CL

Cambridge Financial Group (Arizona)'s CL Position: Q1 2026 in Review

Cambridge Financial Group (Arizona) sold out of Colgate-Palmolive (CL) in Q1 2026, closing a stake of 3,350 shares — an estimated $305K sold.

Cambridge Financial Group (Arizona) first reported a position in CL in Q4 2023 and held it in 9 quarters. The position peaked at $348K in Q3 2024. 1,947 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Cambridge Financial Group (Arizona) reported no remaining Colgate-Palmolive position as of Q1 2026 after selling out during the quarter.
  • Cambridge Financial Group (Arizona) sold 3,350 Colgate-Palmolive shares in Q1 2026, an estimated $305K.
  • Cambridge Financial Group (Arizona) first reported a position in Colgate-Palmolive in Q4 2023 and held it in 9 quarters.
  • Cambridge Financial Group (Arizona)'s Colgate-Palmolive position peaked at $348K in Q3 2024.
  • 1,947 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Cambridge Financial Group (Arizona)'s 13F filing for Q1 2026, filed 8 Apr 2026.